Page last updated: 2024-10-21

4-aminopyridine and Glioblastoma

4-aminopyridine has been researched along with Glioblastoma in 1 studies

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vazana, U1
Veksler, R1
Pell, GS1
Prager, O1
Fassler, M1
Chassidim, Y1
Roth, Y1
Shahar, H1
Zangen, A1
Raccah, R1
Onesti, E1
Ceccanti, M1
Colonnese, C1
Santoro, A1
Salvati, M1
D'Elia, A1
Nucciarelli, V1
Inghilleri, M1
Friedman, A1

Other Studies

1 other study available for 4-aminopyridine and Glioblastoma

ArticleYear
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 07-20, Volume: 36, Issue:29

    Topics: 4-Aminopyridine; Adult; Aged; Animals; Blood-Brain Barrier; Brain Neoplasms; Disease Models, Animal;

2016